7Baggers
 OncoCyte Corp’s Earnings Call: Progress Amid Challenges  TipRanks Mon, 01 Sep 2025 00:21:12 GMT
 published on: 2025-08-31 12:52:37  Newser Sun, 31 Aug 2025 17:52:37 GMT
 published on: 2025-08-30 07:53:59  Newser Sat, 30 Aug 2025 12:53:59 GMT
 published on: 2025-08-29 12:26:56  Newser Fri, 29 Aug 2025 17:26:56 GMT
 published on: 2025-08-29 11:38:05  Newser Fri, 29 Aug 2025 16:38:05 GMT
 published on: 2025-08-29 03:49:07  Newser Fri, 29 Aug 2025 08:49:07 GMT
 published on: 2025-08-28 23:37:18  Newser Fri, 29 Aug 2025 04:37:18 GMT
 published on: 2025-08-28 12:24:54  Newser Thu, 28 Aug 2025 17:24:54 GMT
 published on: 2025-08-25 02:22:14  Newser Mon, 25 Aug 2025 07:22:14 GMT
 published on: 2025-08-24 12:26:40  Newser Sun, 24 Aug 2025 17:26:40 GMT
 published on: 2025-08-23 23:49:45  Newser Sun, 24 Aug 2025 04:49:45 GMT
 published on: 2025-08-23 16:47:47  Newser Sat, 23 Aug 2025 21:47:47 GMT
 published on: 2025-08-21 13:40:14  Newser Thu, 21 Aug 2025 18:40:14 GMT
 published on: 2025-08-19 06:03:02  Newser Tue, 19 Aug 2025 11:03:02 GMT
 published on: 2025-08-16 22:23:20  Newser Sun, 17 Aug 2025 03:23:20 GMT
 Published on: 2025-08-15 03:47:40  뉴스영 Thu, 14 Aug 2025 21:26:54 GMT
 best momentum stocks to buy for may 6th  The Globe and Mail Mon, 11 Aug 2025 16:00:53 GMT

OncoCyte Corporation
(NASDAQ:OCX) 

OCX stock logo

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early stage adenocarcinoma of the lung; and ...

Founded: 2009
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends